论文信息 - Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing - 字舞流文

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

A. Hauschild | D. Schadendorf | I. Lowy | R. Gutzmer | A. Pavlick | Murad Alam | C. Schmults | D. Rischin | C. Ulrich | J. Geiger | A. Chang | B. Hughes | M. Migden | A. Guminski | N. Khushalani | T. Eigentler | L. Hernandez-Aya | M. Fury | B. Modi | V. Janković | E. Stankevich | L. Dunn | A. Lim | J. Booth | Siyu Li | Brian Stein | M. Mathias | E. Okoye